[1] Weinstein G, Goldbourt U, Tanne D. Angina pectoris severity among coronary heart disease patients is associated with subsequent cognitive impairment[J].Alzheimer Dis Assoc Disord,2015, 29(1):6-11. [2] 王新刚.中国15省慢性稳定性心绞痛患者抗心绞痛治疗现状调查[J].中国实用内科杂志,2015,35(1):48-52. [3] Yaman M, Arslan U, 塁ahin M,et al. Effects of trimetazidine on T wave alternans in stable coronary artery disease[J].Korean Circ J,2016, 46(3):343-349. [4] 张军,邓伟,张进,等.心脑康胶囊联合曲美他嗪治疗冠心病心绞痛的临床研究[J].现代药物与临床,2017,32(1):25-29. [5] 国际心脏病学会和世界卫生组织临床命名标准化专题组.缺血性心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1):75. [6] 郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:68-72. [7] 陈智慧,杨关林.诱因差异对冠心病心绞痛患者生存质量的影响[J].辽宁中医杂志,2014,41(6):1092-1094. [8] 王天罡,王凤荣.中医药疗法治疗冠心病心绞痛研究概况[J].中国中医急症,2016,25(6):1074-1076. [9] Senturk T, Cavun S, Avci B, et al. Effective inhibition of cardiomyocyte apoptosis through the combination of trimetazidine and N-acetylcysteine in a rat model of myocardial ischemia and reperfusion injury[J].Atherosclerosis,2014, 237(2):760-766. [10] 陈章生,兰智慧,甘桃梅,等.从湿辨治对痰浊内阻证冠心病心绞痛患者血液流变学的影响及疗效观察[J].世界中西医结合杂志,2015,10(5):656-658. [11] 刘丽.心脑康胶囊的临床应用[J].吉林医学信息,2009,26(1~4):3-4.
2019, Vol. 36 
